HA
ABBV icon

Herold Advisors’s AbbVie ABBV Stock Holding History

Herold Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.92M Sell
34,107
-1,016
-3% -$260K 1.74% 10
2026
Q2 		$8.83M Buy
35,123
+33
+0.1% +$7.1K 1.75% 11
2026
Q1 		$7.63M Hold
35,090
– – 1.68% 11
2025
Q4 		$8.02M Sell
35,090
-757
-2% -$172K 1.79% 10
2025
Q3 		$8.3M Buy
35,847
+1,683
+5% +$343K 1.92% 6
2025
Q2 		$6.34M Sell
34,164
-1,802
-5% -$335K 1.33% 15
2025
Q1 		$7.54M Sell
35,966
-1,776
-5% -$345K 1.65% 9
2024
Q4 		$6.71M Sell
37,742
-1,002
-3% -$184K 1.46% 11
2024
Q3 		$7.65M Sell
38,744
-405
-1% -$75.6K 1.66% 7
2024
Q2 		$6.72M Buy
39,149
+804
+2% +$133K 1.55% 8
2024
Q1 		$6.98M Sell
38,345
-433
-1% -$74.6K 1.69% 8
2023
Q4 		$6.01M Buy
38,778
+682
+2% +$99.4K 1.66% 9
2023
Q3 		$5.68M Buy
38,096
+2,568
+7% +$377K 1.73% 9
2023
Q2 		$4.79M Buy
35,528
+1,558
+5% +$228K 1.47% 10
2023
Q1 		$5.41M Buy
33,970
+38
+0.1% +$5.81K 1.87% 8
2022
Q4 		$5.48M Buy
33,932
+1,534
+5% +$235K 2.32% 5
2022
Q3 		$4.35M Buy
32,398
+289
+0.9% +$41.5K 2.09% 5
2022
Q2 		$4.92M Buy
32,109
+264
+0.8% +$40.3K 2.19% 5
2022
Q1 		$5.16M Buy
31,845
+1,173
+4% +$170K 1.84% 6
2021
Q4 		$4.15M Sell
30,672
-141
-0.5% -$16.7K 1.61% 9
2021
Q3 		$3.32M Buy
+30,813
New +$3.52M 1.29% 8

Other funds holding ABBV

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Herold Advisors's ABBV Position: Q3 2026 in Review

Herold Advisors reduced its AbbVie (ABBV) stake by 2.9% in Q3 2026, selling an estimated $260K and leaving 34,107 shares worth $8.92M. The position accounts for 1.74% of the portfolio, ranked #10.

Herold Advisors first reported a position in ABBV in Q3 2021 and has held it in 21 quarters since. 849 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Herold Advisors held 34,107 shares of AbbVie worth $8.92M as of Q3 2026.
  • Herold Advisors sold 1,016 AbbVie shares in Q3 2026, an estimated $260K.
  • AbbVie made up 1.74% of Herold Advisors's portfolio in Q3 2026, its #10 holding.
  • Herold Advisors first reported a position in AbbVie in Q3 2021 and has held it in 21 quarters since.
  • 849 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Herold Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.